Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study Meeting Abstract


Authors: Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; Comenzo, R.
Abstract Title: Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study
Meeting Title: 51st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 114
Issue: 22
Meeting Dates: 2009 Dec 5-8
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2009-11-20
Start Page: 222
End Page: 223
Language: English
ACCESSION: WOS:000272725800534
PROVIDER: wos
PUBMED: 22276299
Notes: Meeting Abstract: 533 -- Source: Wos
MSK Authors
  1. Hani Hassoun
    149 Hassoun
  2. Stephen D Nimer
    345 Nimer
  3. Heather Jolie Landau
    189 Landau
  4. Alexander Meyer Lesokhin
    118 Lesokhin
  5. Christina Bello
    15 Bello
  6. Elizabeth Hoover
    19 Hoover